Announcement on Foreign Investment of Subsidiary Peak Pharmaceutical
Release time:
2020-08-05
证券代码:600668 证券简称:尖峰集团 公告编号:临2018-002
债券简称:13尖峰01 债券代码:122227
债券简称:13尖峰02 债券代码:122344
浙江尖峰集团股份有限公司
关于子公司尖峰药业对外投资的公告
本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏,并对其内容的真实性、准确性和完整性承担个别及连带责任。
重要内容提示:
l 交易简要内容:本公司控股子公司浙江尖峰药业有限公司(以下简称:尖峰药业)拟投资11132.79万元以收购股份和增资的方式对上海北卡医药技术有限公司(以下简称:上海北卡)进行投资。投资完成后,上海北卡注册资本由原来的1100万元增加至1755.55万元,其中尖峰药业占55%。
l 本次交易不构成关联交易
l 本次交易不构成重大资产重组
l 本次股权收购和增资事项经公司董事会审议后无需提交股东大会审议批准。
一、对外投资概述
(一)2018年1月19日,本公司控股子公司浙江尖峰药业有限公司和康立涛、李倩、郑亚玲、海南寰太生物医药产业创业投资基金合伙企业、上海北卡签订了《关于上海北卡医药技术有限公司之增资和股权转让协议》,尖峰药业拟投资11132.79万元以收购股份和增资的方式对上海北卡医药技术有限公司(以下简称:上海北卡)进行投资。投资完成后,上海北卡注册资本由原来的1100万元增加至1755.55万元,其中尖峰药业占55%。尖峰药业将以上海北卡及其子公司为平台建立原料药及中间体的研发、生产基地。
(二)董事会审议情况
2018年1月19日,公司以通信方式召开了第十届董事会第二次会议,公司现有九名董事,全部参加了会议,经审议与表决,董事会以9票同意、0票反对、0票弃权审议并通过了该事项。独立董事发表了独立意见。
(三)根据上海证券交易所《股票上市规则》和公司《章程》等有关规定,公司本次对外投资属董事会权限范围,无需提交股东大会审议。该合作事项不属于关联交易,也不构成《上市公司重大资产重组管理办法》规定的重大资产重组情况。
二、交易对方的基本情况
(一)康立涛,男,中国国籍,住址:上海市松江区影佳路***弄***号,职业:上海北卡董事长。
(二)李倩,女,中国国籍,住址:上海市浦东新区益丰路**弄***室,职业:上海北卡总经理。
(三)郑亚玲,女,中国国籍,住址:重庆市渝中区建兴坡***号,职业:重庆金赛医药有限公司董事长。
(四)海南寰太生物医药产业创业投资基金合伙企业
1、企业名称:海南寰太生物医药产业创业投资基金合伙企业(有限合伙)
2、企业性质:有限合伙企业
3、注册地:海口市龙华区国贸大道56号北京大厦21层C、D
4、注册日期:2015年02月11日
5、主要办公地点:海口市龙华区国贸大道56号北京大厦21层C、D
6、执行事务合伙人:海南寰太股权投资基金管理有限公司
7、经营范围:创业投资业务,创业投资咨询业务,为创业企业提供创业管理服务业务。
三、交易标的基本情况
(一)标的公司的基本情况
1、企业名称:上海北卡医药技术有限公司
2、企业性质:有限责任公司(国内合资)
3、注册地:上海市松江区申港路3802号21幢
4、注册日期:2003年10月20日
5、主要办公地点:上海市松江区申港路3802号21幢
6、法定代表人:康立涛
7、注册资本:1100万元
8、经营范围:医药和化学专业技术领域内的技术开发、技术咨询、技术服务、技术转让;机械设备、仪器仪表、食用农产品(不含生猪产品)、化肥、饲料添加剂、化工原料及产品(除危险品)批发零售;医药中间体的开发、销售;从事货物及技术的进出口业务。(依法须经批准的项目,经相关部门批准后方可开展经营活动)
9、主要股东:
|
序号 |
股东名称 |
出资额(万元) |
出资比例(%) |
|
1 |
康立涛 |
493.26 |
44.8418 |
|
2 |
李倩 |
306.74 |
27.8855 |
|
3 |
郑亚玲 |
200 |
18.1818 |
|
4 |
海南寰太生物医药产业创业投资基金合伙企业 |
100 |
9.0909 |
|
|
合计 |
1100 |
100 |
10、业务情况
上海北卡是上海市高新技术企业,上海市“专精特新”科技企业、“上海市专利试点企业”,建有院士专家工作站和松江区“企业技术中心”,有多项 “上海市高新技术成果转化项目”成果,曾荣获“上海市松江区科技进步二等奖”等。上海北卡有较强的研发能力,已获得14项专利。其总部设在上海市松江区申港路3802号“新飞企业家园”内,租有三栋独立的厂房用于研发和办公,合计面积1787.91平方米。目前主要业务为国内外制药企业提供产品和定制服务,产品主要包括替尼类、生物碱类、糖类等抗肿瘤药物中间体等,定制服务主要是新药和中间体的CDMO(合约开发制造)。
上海北卡拥有两家全资子公司,安徽常泰化工有限公司(以下简称:常泰化工)和安徽北卡医药有限公司(以下简称:安徽北卡)。
常泰化工是工信部定点的农药生产企业,是上海北卡通过收购获得的全资子公司,成立于2007年7月,注册资本3000万元,经营范围:间苯氧基苯基氰基甲醇、一甲胺盐酸盐、2-氯-5-氯甲基吡啶、啶虫脒原药、联苯菊酯原药、虱螨脲原药、农药制剂的水剂、乳油类制剂、微乳剂、可湿性粉剂、盐酸厄洛替尼、吉非替尼、达沙替尼及以上药物的中间体的开发、生产、销售;20%亚磷酸、乙醇、甲醇、甲苯、环己烷、N,N-二甲基甲酰胺(DMF)、丙烯腈、40%一甲胺水溶液,生产、销售;化工原料及产品(不含危化品)的批发、零售。住所:安徽省池州市东至县香隅镇化工园区。占地78,351.51平方米,现拥有三个化学合成车间和一个农药制剂复配车间,拥有10个产品批文,13项专利。常泰化工将在现有业务的基础上,进一步向医药中间体方向延伸。
安徽北卡成立于2016年12月,注册资本1000万元,经营范围:化学原料药和医药中间体的定制、生产和销售,化工原料及产品的批发和零售(危化品除外);生物技术,新型化合物药物、活性成分药物及药用化合物的技术开发、咨询、服务和转让。住所:安徽东至经济开发区。安徽北卡还获批承担安徽省重大新兴产业工程项目“小分子靶向药物制造基地”,将建设成以医药原料药为主的生产基地,以承接上海北卡的成果转化。
(二)标的公司2016年和2017年合并财务报表情况
截至2017年末,上海北卡合并资产总额8990.76万元、负债总额7452.97万元、归属于母公司股东权益1537.79万元;2017年合并营业收入8490.31万元、归属于母公司所有者净利润-652.55万元;截至2016年末,上海北卡合并资产总额8852.27万元、负债总额5423.27万元、归属于母公司股东权益2294.23万元。2016年度合并营业收入7056.74万元、归属于母公司所有者净利润-203.18万元。
2016年度的财务数据经具有证券、期货从业资格的毕马威华振会计师事务所(特殊普通合伙)审计,2017年度的财务数据未经审计。
(三)交易标的评估情况
本次交易委托具有证券从业资格的坤元资产评估有限公司对上海北卡股东的全部权益价值进行评估。坤元资产评估有限公司所出具了《资产评估报告》(坤元评报〔2017〕1-37号),上海北卡股东的全部权益价值评估价值为12280.19万元,评估基准日为2017年9月30日。
评估公司本次评估分别以资产基础法和收益法进行了评估,由于资产基础法固有的特性,资产基础法中无法单独考虑企业的人力资源、客户资源、管理内控水平、要素协同等因素对企业价值的影响,其评估结果未能涵盖企业的全部资产的价值,且资产基础法以企业单项资产的再取得成本为出发点,有忽视企业的获利能力的可能性,由此导致资产基础法与收益法两种方法下的评估结果产生差异。根据北卡医药公司所处行业和经营特点,收益法评估价值能比较客观、全面地反映目前企业的股东全部权益价值。
因此,本次评估最终采用收益法评估结果122,801,900.00元(大写为人民币壹亿贰仟贰佰捌拾万壹仟玖佰元整)作为北卡医药公司股东全部权益的评估值。
(四)上海北卡最近一次增资的情况。
2016年10月,上海北卡曾进行增资,注册资本从1000万元增加到1100万元,海南寰太出资人民币1000万元,其中:100万元记入注册资本,900万元记入资本公积。
(五) 权属状况说明
交易对方所持的上海北卡股权产权清晰,不存在抵押、质押情况,不涉及诉讼、仲裁事项或查封、冻结等司法措施。
四、协议的主要内容
2018年1月19日,尖峰药业(甲方或“投资方”)和原股东康立涛、李倩、郑亚玲、海南寰太生物医药产业创业投资基金合伙企业(合称乙方)、上海北卡(丙方或标的公司)签订了《关于上海北卡医药技术有限公司之增资和股权转让协议》。协议的主要内容有:
(一)增资和股权转让
1.1各方同意,甲方为本次交易的唯一股权受让方和增资方,本次股权转让出资额310万元和全部新增股权出资额655.55万元均由投资方受让和认缴。交易价格以评估值为基础,各方协商确定。标的公司股东全部权益作价12680万元,每股(元)转让和增资价格均为11.53元,甲方总投资金额为11132.79万元(其中:股权转让款为3574.30万元、增资款为7558.49万元,若有扣除金额则相应减少股权转让款)。
1.1.1原股东康立涛本次出让股权74.00万,股权转让款为853.22万元;
原股东李倩本次出让股权46.00万,股权转让款为530.38万元;
原股东郑亚玲本次出让股权90万,股权转让款为1037.70万元;
原股东海南寰太本次出让股权100万,股权转让款为1153万元。
1.1.2甲方出资7558.49万元,认缴本次标的公司新增注册资本655.55万元。
1.1.3甲方投资完成后,标的公司注册资本增加655.55万元,即注册资本由原1100万元增至1755.55万元。其中:甲方占55%、康立涛占23.88%、李倩占14.85%、郑亚玲占6.27%。
1.2股权转让款的分期支付及分期增资
协议各方一致同意按以下方式,由甲方按股权比例向乙方分别支付股权转让款,并在满足每期相关条件后的15工作日内支付:
1.2.1第一期支付金额为原股东康立涛、李倩、郑亚玲股权转让款的30%、原股东海南寰太股权转让款的100%,总计1879.39万元。应满足以下付款条件:
具备本协议生效条件,本协议生效。
1.2.2第二期支付金额为原股东康立涛、李倩、郑亚玲股权转让款的50%,总计1210.65万元。应满足以下付款条件,
1.2.2.1 协议各方签署《交接协议》,协议各方完成交接,并不存在交接不清、影响日后工作的事项。
1.2.2.2完成股权转让的工商变更登记,达到权利方能合法行使股权。
1.2.3第三期支付金额为减去“扣除金额”后剩余的股权转让款项,应满足以下付款条件:
1.2.3.1甲方在《交接协议》签订一年内,且乙方已履行本协议项下的全部义务,分两次支付给乙方。
1.2.3.2 提供足额完税证明。
若出现“扣除金额”的情形,甲方或标的公司可通过下列途径要求乙方承担或追偿垫付的款项和利息损失:①从应付原个人股东的股权转让款项中扣除,或②原个人股东直接承担或向甲方、标的公司偿还,或③从原个人股东以后公司分红款中扣回或划付,或④通过法律渠道向原个人股东追偿。
1.2.4甲方支付乙方股权转让款到指定的原股东的银行帐户、账号。
1.2.5各方同意,本协议生效后15日内支付第一期增资款4612万元(对应出资额400万元);剩余增资款2946.49万元(对应出资额255.55万元)在本协议生效后半年内出资到位。
1.3各方同意,投资方应将本协议约定的各期投资金额按约定条件,以现金方式付至公司账户或股东账户。
1.3.1在本协议约定的全部条件满足后,标的公司、股权转让方应按照本协议约定向投资方提供董事会决议、股东会决议、修改后的公司章程或章程修正案、股权转让协议(每次/每人)等文件正本并获得投资方的书面认可。
1.3.2投资方在收到本协议相应条款所述文件/条件后15个工作日内支付当期投资价款。如果投资方未按照本条的规定及时支付当期投资价款,则投资方应当就迟延支付部分的金额按银行同期贷款利率计算的利息向标的公司和/或原股东支付逾期缴付的违约金。如投资方未在本协议约定的各期投资应到位日后的15日内支付当期投资价款,则标的公司和/或原股东有权解除本协议。
1.4 投资方成为公司股东后,依照法律、本协议和公司章程的规定享有所有股东权利并承担相应股东义务,公司的资本公积金、盈余公积金和未分配利润由投资方和公司原股东按本协议确定的股权比例享有。
1.5各方同意,投资方对标的公司的全部出资不得用于委托贷款和委托理财等风险投资。
1.6本合同约定的第一期增资款到位并办理交接手续后3个月内,标的公司应向原股东清偿所有股东借款(431.3万元)。
1.7双方同意,在本协议签订后变更标的公司章程,在遵守《公司法》、《会计准则》及上市公司监管要求,并且保证正常生产经营的前提下,原则上标的公司每年现金分红比例不少于当年实现的可分配利润的30%(全体股东另行达成一致的情况除外)。
1.8未来股权安排
1.8.1原个人股东承诺,除非本协议另有约定或协议各方达成一致,自本次转让增资的工商变更登记手续完成后八年内不转让其所有持的标的公司股权,也不得在其股权上设置任何质押、担保等权利负担。八年后若原个人股东拟出让其股权,须符合法律法规、上市公司监管要求,并在标的公司(合并报表)每年扣非后净利润不低于3000万元,或三年累计扣非后净利润不低于9000万元的前提下(提出转让提案前三年),各方可协商甲方或第三方以现金或其他合法方式分批收购原个人股东持有的标的公司股权;甲方或第三方应在不晚于原个人股东向甲方提出转让提案后的三年内完成对原个人股东持有的全部股权的收购。
1.8.2收购价格应按市场价格确定或以双方共同认可的评估值为基础且不低于标的公司净资产的基础上协商确定。
1.9在合作期间,如协议各方向非同一实际控制人的第三方出让标的公司股权,应保证受让方按同等条件收购协议其他方所持有的全部股权。
(二)变更登记手续与交接
2.1各方同意,在本协议生效、甲方支付第一期股权转让款和第一期增资款后15个工作日内,由标的公司负责完成工商登记变更手续(包括但不限于按本协议修改并签署的公司章程及按本协议规定选举的董事、监事等在登记机关的变更备案)。
2.2如果公司未按时办理登记变更手续,且逾期超过30天仍无法办理相应的变更登记手续(由于政府方面原因或不可抗力的因素情形除外),投资方有权以书面通知的形式提出终止本协议,公司和/或原股东应于本协议终止后15个工作日内退还投资方已经支付的全部投资价款(包括股权转让款和增资款),并支付违约金(按该笔款项银行同期贷款利率计算)。但如果投资方同意豁免的情形除外。
2.3办理变更登记或备案手续所需费用由标的公司承担。
2.4交接
2.4.1协议各方同意在本协议生效15个工作日内,甲方派员与乙方在其经营场所进行交接,乙方应保证上述接收人员的进入,并协助接收人员对本协议规定的全部资产、资料进行清点,确保交接的顺利完成,接收人员对所接收的资产、资料等审核确认后,进行妥善置放。
(三)公司治理
3.1各方同意并保证,投资完成后,标的公司董事会成员五人,甲方提名三人、原股东提名二人担任标的公司董事;公司的董事长、法定代表人由投资方提名的董事担任。标的公司应在办理营业执照变更的同时办理董事变更手续。标的公司新董事会至少每半年召开一次董事会会议。标的公司设监事会,监事成员三人,甲方提名二人、原股东提名一人;公司监事会主席由投资方提名的监事担任。
3.2各方同意并保证,所有标的公司董事、监事和高级管理人员的任职资格均应当符合有关法律法规的规定。当上述任何一方提名的董事、监事辞任或者被解除职务时,由提名该董事、监事的一方继续提名继任人选,各方并应保证在相关公司权力机构上投票赞成该等人士担任公司董事、监事。
3.3公司总经理、副总经理、财务总监等高级管理人员由董事会聘任,高级管理人员的薪酬由董事会决定。公司应按照《公司法》、上市公司监管要求不断完善公司治理、完善财务等内控制度,并尽快建立对核心团队成员的激励制度。
(四)清算财产的分配
各方同意,如公司清算,先按所有股东实际投入现金比例进行分配,超出各股东的实际投入现金以上部分再按照股份比例分配。
(五)债务和或有债务
5.1原控股股东及公司承诺并保证,除已向投资方披露之外,公司并未签署任何对外担保性文件,亦不存在任何其他未披露的债务。如标的公司还存在未反映在公司财务报表中的或未披露的或有负债或者其他债务,全部由原股东和原控股股东承担。若公司先行承担并清偿上述债务,因此给公司造成损失,原控股股东和原股东应当在公司实际发生损失后5个工作日内,向公司全额赔偿,原控股股东和原股东应以其股权转让款,或从公司取得的分红,或从其他合法渠道筹措的资金履行赔偿义务。
(六)协议生效及其他
6.1除非本协议另有规定,各方应自行支付其各自与本协议及本协议述及的文件的谈判、起草、签署和执行的有关成本和费用。有关公司增资审批、审计、工商变更登记等费用由公司自行承担。本次交易中所涉及的税费,由各方根据相关法律的规定缴纳。
6.2 本协议在下述条件获得完全满足时生效:
6.2.1本协议由各方法定代表人或授权代表签字并加盖公章。
6.2.2本协议获得各方有权机构的正式批准。
6.3履行本协议时,各方将在此基础上签署工商登记所需的相关增资协议、公司章程、股权转让协议及其他必要文件。
五、本次合作对公司的影响及风险提示
(一)本次合作是根据公司“合作创新强主业、规范科学求发展”战略方针,加强医药业务板块发展的重要举措,如果该项合作能顺利完成,上海北卡及其子公司将成为尖峰药业的控股子公司,尖峰药业将以上海北卡及其子公司为平台建立原料药及中间体的研发、生产基地,进一步延伸并完善医药业务的产业链,有利于增加公司的医药产业规模,有利于提高尖峰药业的研发能力,有利于加强尖峰药业原料药生产保障,有利于提升尖峰药业的综合实力。
(二)本次对外投资的资金来源为公司的自有资金。
(三)本次对外投资对公司当期利润不会造成重大影响。
(四)风险提示:该项目投资的风险主要包括市场风险、技术风险、政策风险等。市场风险:受近年来化工原材料价格上升、能源成本增加、环保投入逐渐加大、市场价格不断变化等因素的影响,未来原料药品市场竞争形势存在一定的不确定性。技术风险:若标的公司所采用技术的先进性、可靠性、适用性和可行性与实际情况发生重大变化,将可能导致生产能力利用率降低,生产成本增加,产能达不到预期要求。政策风险:由于税收、环保、产业政策等的不断调整,将使税率、利率、环保要求等发生变化,将可能导致标的公司原定目标难以实现。
公司将根据合作事项的进度及时披露后续进展情况,敬请广大投资者注意投资风险。
特此公告
浙江尖峰集团股份有限公司
董事会
二〇一八年一月一十九日
More information
July 1 is the anniversary of the founding of the Communist Party of China. The party committee of the group organized the party members of the group headquarters and the heads of the grassroots party organizations to go to Jinggangshan, the red holy land, to retake the revolutionary road taken by the ancestors and review the history of revolutionary struggle.
2023
07-11
The Party Committee of the Group organized a thematic education seminar to study
On June 27, the Party Committee of the Group Company organized an education seminar on the theme of studying and implementing Xi Jinping's thoughts on socialism with Chinese characteristics in the new era. Jiang Xinwang, a professor and master tutor of Zhejiang Normal University, explained the deployment requirements of economic work and Xi Jinping's economic thoughts in the report of the 20th National Congress of the Communist Party of China with the theme of "accelerating the construction of a new development pattern and promoting high-quality development.
2023
07-11
Jianfeng Pharmaceutical rehired Academician Wang Guangji as Chief Scientist
On April 30, Jiang Xiaomeng, chairman of the group company and chairman of Jianfeng Pharmaceutical Company, on behalf of Jianfeng Pharmaceutical Company, issued a letter of appointment to Professor Wang Guangji, academician of the Chinese Academy of Engineering, and renewed him as the chief scientist of the pharmaceutical company.
2023
05-11
Jinhua Development Conference and Wucheng Development Conference
On April 30 and May 1, the third Jinhua Development Conference and the second Wucheng Development Conference opened successively. Jiang Xiaomeng, secretary of the party committee and chairman of the group company, won two major awards at the "Jinhua Development Outstanding Achievement Award" and "Wucheng Development Merit Award" at the two conferences, and participated in the Jinhua Life and Health Industry Summit roundtable and other activities.
2023
05-11
Daye Peak Cement Company, National "Green Factory"!
The Ministry of Industry and Information Technology recently announced the 2022 national green manufacturing list, Daye Peak Cement Company successfully ranked among the national "green factories. Green manufacturing is also known as environmentally conscious manufacturing, that is, in the manufacturing process, a modern manufacturing model that comprehensively considers environmental impact and resource benefits. Its purpose is to use technical means to optimize manufacturing procedures, minimize the impact on the environment (negative effect), and resource utilization The highest rate, and the coordination and optimization of economic and social benefits of enterprises, so as to achieve the purpose of resource conservation and sustainable development. In recent years, with the rapid development of social economy, the state attaches great importance to the construction of ecological civilization and ecological environment protection, and further promoting the construction of green manufacturing system has become an important means to promote high-quality development and maintain green water and green mountains forever. As an important part of the green manufacturing system, the Ministry of Industry and Information Technology has organized and carried out the creation of national-level green factories since 2017, and has conducted nationwide selection. It is an authoritative recognition for companies that meet the "green development" and aims to improve my country's green Manufacturing system, comprehensive implementation of green manufacturing, and help the industrial sector achieve the goal of carbon peak and carbon neutrality, it is an important way to promote the structural optimization of various industries, to get out of trouble and upgrade, and to improve quality and efficiency. Green factory refers to the realization of land intensive, raw materials harmless, clean production, waste resources, energy low-carbon factories. As the production unit of the manufacturing industry, the factory is the main body of the implementation of green manufacturing, which belongs to the core support unit of the green manufacturing system, focusing on the greening of the production process. Over the years, Daye Jianfeng has been adhering to the concept of green and low-carbon development, making every effort to build a garden-style factory. Through formulating plans and subdividing targets, it has clearly defined the total energy consumption and pollutant emission targets, and through carrying out school-enterprise cooperation to promote industry-university-research, it has actively implemented the strategy of "carbon peak and carbon neutrality", invested a huge amount of funds every year for technological transformation, and successively implemented technological transformation projects such as electric bags and low-nitrogen combustion upgrading, take the lead in the application of emission reduction technologies such as wet desulfurization and precise denitrification in the cement industry in Hubei Province, and continue to promote energy conservation, consumption reduction, and emission reduction. After the technical transformation, the company can save 3000 tons of standard coal every year, reduce the intensity of carbon dioxide emissions by 3.6, improve the level of energy-saving and green environmental protection management, and achieve the goal of creating a green factory. Being rated as a national-level green factory is not only a high affirmation and encouragement of Daye Peak's adherence to green, low-carbon and innovative development, but also an opportunity for Daye Peak to further promote green development. The person in charge of Daye Peak said that in accordance with national requirements, local industrial and information authorities should strengthen the connection between the units listed in the green manufacturing list and relevant industrial policies, give full play to the demonstration role of point to area, lead the green transformation of the manufacturing industry in the region, strengthen tracking guidance and dynamic management, and review the key indicators specified in the dynamic management table, Daye Peak will be in the future work, we will continue to further promote the management of environmental protection, energy conservation and emission reduction, give full play to the leading role of green factories in benchmarking, make low-carbon energy conservation, green environmental protection and reduce energy consumption the main keynote of enterprise development, and make continuous efforts to promote the high-quality development of enterprises and local economy. (Junin)
2023
04-03
"Cement Economy 50 People Forum" Jiang Xiaomeng Talk about the Future Development of Cement Industry
On March 14, the "Cement Economy 50 Forum" hosted by China Cement Network was held in Hangzhou, inviting 50 influential economic figures in the cement industry to discuss the future development of China's cement industry. Jiang Xiaomeng, chairman of the group company, was invited to attend the forum to discuss the development of the cement industry with his peers. The theme of this forum is "strengthening confidence, seeking breakthrough, and promoting development". It aims to point out the disadvantages of "mud", actively provide suggestions for the competent departments, enterprise transformation and upgrading, strategic and tactical decision-making in the difficult period of the cement industry, and provide new think tank opinions and methods to help form a new cement economic ecology. In the context of the sharp decline in demand, the cement industry is trapped inside and outside, how to revive the glory? How do cement companies survive and develop next? Around these two topics, the guests at the meeting had a heated discussion. Jiang Xiaomeng pointed out in his speech at the forum that the development of any enterprise is inseparable from the healthy development of the industry. Only when the industry is good can the enterprise be good, and the interests of the industry are greater than the interests of the enterprise. In addition, the competition of similar enterprises should seek a breakthrough from the differentiation, and it is unreasonable to blindly pursue low prices. Industry synergy, industry synergy, supply, demand, price, to find a common price line, on the basis of competition and cooperation, from the management services, cost control and other aspects to highlight the advantages of enterprises. The participants reached consensus on many issues after heated discussions. It is generally believed that 2022 is the most complex year in the cement industry in the past decade, affected by the multi-point spread of the epidemic, real estate downturn and other factors, the cement market demand is sluggish, the contradiction between supply and demand is prominent, prices are falling rapidly, business difficulties, the pace of steady growth of the industry is blocked. Entering 2023, under the macroeconomic situation of stabilizing the economy and promoting development, as well as various regions stepping up efforts to promote the construction of major projects, cement demand is expected to increase in 2023 compared with 2022, and the situation in the second half of the year will be better than that in the first half. However, under the expectation of restorative growth in demand, the cement industry is still facing uncertainties such as continued bottoming of real estate, high energy costs, and overcapacity. In this regard, we should resolutely maintain the normal order of the industry, make concerted efforts to help the industry get out of the predicament, and firmly implement staggered peak production. Through mergers and acquisitions, carbon quotas, energy efficiency indicators, environmental protection indicators, coal indicators, market competition and other means to further resolve the contradiction of overcapacity, optimize the industrial layout, and adhere to innovation-driven in digital, intelligent and green development, so as to promote and finally realize the high-quality development of the cement industry. (this newspaper reporter)
2023
03-21